Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Tocotrienols, a subgroup of the vitamin E family, have garnered interest for their potential lipid-lowering effects, including on triglyceride levels. Scientific evidence primarily comes from small human clinical trials and animal studies. Some randomized controlled trials (RCTs) have shown that tocotrienol supplementation can lead to modest reductions in serum triglycerides, especially in individuals with mild hyperlipidemia. For example, a 2011 double-blind, placebo-controlled study published in the journal Nutrition & Metabolism found that mixed tocotrienol supplementation significantly reduced triglyceride levels in hypercholesterolemic subjects over a 12-week period. Other studies have reported similar findings, though results are not always consistent and effect sizes are generally modest.

The mechanisms proposed include inhibition of hepatic HMG-CoA reductase (the rate-limiting enzyme in cholesterol synthesis), enhanced fatty acid oxidation, and improved lipid metabolism. However, the number of high-quality, large-scale studies remains limited, and some trials have failed to show a significant impact on triglycerides. Meta-analyses note heterogeneity in study design, dosage, and tocotrienol source, making definitive conclusions challenging.

In summary, there is emerging but not yet robust scientific evidence supporting the use of tocotrienols to help lower elevated triglycerides. While promising, further large, well-controlled clinical trials are needed to confirm these effects and establish optimal dosing strategies.

More about tocotrienols
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by tocotrienols

Products containing tocotrienols

Vitabase Cholesterol Support
Designs For Health DIM-Evail™
Vitabase Perfect E